Assay Detail
Functional
CHEMBL5120183
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Antiproliferative activity against human HepG2 cells by MTT assay
34
Total Activities
34
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | HepG2 |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Design and Characterization of a Natural Arf-GEFs Inhibitor Prodrug <b>CHNQD-01255</b> with Potent Anti-Hepatocellular Carcinoma Efficacy <i>In Vivo</i>.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 34 | 6.36 | 7.10 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL19980 | BREFELDIN A | — | 1 | 7.10 |
| CHEMBL5174852 | — | — | 1 | 7.00 |
| CHEMBL5201025 | — | — | 1 | 6.54 |
| CHEMBL5169612 | — | — | 1 | 6.47 |
| CHEMBL53463 | DOXORUBICIN | 4.0 | 1 | 6.41 |
| CHEMBL5180436 | — | — | 1 | 6.34 |
| CHEMBL5179051 | — | — | 1 | 6.19 |
| CHEMBL5196044 | — | — | 1 | 6.17 |
| CHEMBL5176110 | — | — | 1 | 6.07 |
| CHEMBL5179187 | — | — | 1 | 6.03 |
| CHEMBL5186526 | — | — | 1 | 6.02 |
| CHEMBL5193060 | — | — | 1 | 6.02 |
| CHEMBL5206820 | — | — | 1 | - |
| CHEMBL5200912 | — | — | 1 | - |
| CHEMBL5182110 | — | — | 1 | - |
| CHEMBL5170233 | — | — | 1 | - |
| CHEMBL5174455 | — | — | 1 | - |
| CHEMBL5186543 | — | — | 1 | - |
| CHEMBL5191202 | — | — | 1 | - |
| CHEMBL5181256 | — | — | 1 | - |
| CHEMBL5192341 | — | — | 1 | - |
| CHEMBL5189771 | — | — | 1 | - |
| CHEMBL5205595 | — | — | 1 | - |
| CHEMBL5201225 | — | — | 1 | - |
| CHEMBL5190080 | — | — | 1 | - |
| CHEMBL5188881 | — | — | 1 | - |
| CHEMBL5203745 | — | — | 1 | - |
| CHEMBL5185173 | — | — | 1 | - |
| CHEMBL5178957 | — | — | 1 | - |
| CHEMBL5181330 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL19980 | BREFELDIN A | IC50 | = | 80.0 | nM | 7.10 |
| CHEMBL5174852 | — | IC50 | = | 100.0 | nM | 7.00 |
| CHEMBL5201025 | — | IC50 | = | 290.0 | nM | 6.54 |
| CHEMBL5169612 | — | IC50 | = | 340.0 | nM | 6.47 |
| CHEMBL53463 | DOXORUBICIN | IC50 | = | 390.0 | nM | 6.41 |
| CHEMBL5180436 | — | IC50 | = | 460.0 | nM | 6.34 |
| CHEMBL5179051 | — | IC50 | = | 650.0 | nM | 6.19 |
| CHEMBL5196044 | — | IC50 | = | 680.0 | nM | 6.17 |
| CHEMBL5176110 | — | IC50 | = | 850.0 | nM | 6.07 |
| CHEMBL5179187 | — | IC50 | = | 930.0 | nM | 6.03 |
| CHEMBL5193060 | — | IC50 | = | 960.0 | nM | 6.02 |
| CHEMBL5186526 | — | IC50 | = | 950.0 | nM | 6.02 |
| CHEMBL5170004 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5179555 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL1974558 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5173728 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5206820 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5200912 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5182110 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5170233 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5174455 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5186543 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5191202 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5181256 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5192341 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5189771 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5205595 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5201225 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5190080 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5188881 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5203745 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5185173 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5178957 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL5181330 | — | IC50 | > | 1000.0 | nM | - |